Mission：To invest in healthcare and create good life
GIG has an AUM of ￥20 B and has raised 24 funds dedicating to the healthcare industry. GIG has invested in more than 130 companies, 60 of which are in the healthcare industry. Ten of our portfolio companies have gone through IPO, and notably, GIG also acts as the holding company of Boya Bio-Pharmaceutical (SZ.300294) ---- a domestic leader in blood products.
Vision：Devoted to be a globally influential
healthcare investment group
Founded in Shenzhen in 2001, GTJA INVESTMENT GROUP (GIG) is dedicated to investment in healthcare industry with focus on strategic equity investment. GIG is involved in the entire investment stages which includes M&A, PE, VC, and angel investment. Currently, GIG has the largest and most professional team for healthcare investment in China. We have established an eco platform in healthcare investment sectors, and is devoted to become a healthcare investment institution with global influence.
Large Proportion：We invest in a large proportion of share in order to secure reasonable control. We are often the lead investor and may be the majority shareholder from time to time.
Long Term：We invest in a long-term. As we are able to identify the winners, we would stay with the enterprises and benefit from their long-term growth.
Active Participation：We exploit our industry expertise to promote competitiveness of the portfolio companies. We also train the management teams from different investees and encourage them to communicate regularly.
Full Stage：We conduct full stages investment, from early stage angel to PIPE. Having the whole picture of the industry in our mind, we are able to envisage the growth of companies in each stage.